Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia Pablo Lázaro, MD, PhD, MBA, Leopoldo Pérez de Isla, MD, PhD, Gerald F. Watts, DSc, MD, Rodrigo Alonso, MD, PhD, Richard Norman, PhD, MSc, Ovidio Muñiz, MD, PhD, Francisco Fuentes, MD, PhD, Nelva Mata, MD, PhD, José López-Miranda, MD, PhD, José Ramón González-Juanatey, MD, PhD, José Luis Díaz-Díaz, MD, PhD, Antonio Javier Blasco, MPH, PhD, Pedro Mata, MD, PhD Journal of Clinical Lipidology Volume 11, Issue 1, Pages 260-271 (January 2017) DOI: 10.1016/j.jacl.2017.01.002 Copyright © 2017 National Lipid Association Terms and Conditions
Figure 1 Decision tree structure (simplified) for the model. Journal of Clinical Lipidology 2017 11, 260-271DOI: (10.1016/j.jacl.2017.01.002) Copyright © 2017 National Lipid Association Terms and Conditions
Figure 2 Diagnostic tests results in index cases and relatives. Journal of Clinical Lipidology 2017 11, 260-271DOI: (10.1016/j.jacl.2017.01.002) Copyright © 2017 National Lipid Association Terms and Conditions
Figure 3 Incremental cost-utility ratio (cost per QALY gained) of the NPFH implementation considering the payer and social perspectives: sensitivity analysis. Journal of Clinical Lipidology 2017 11, 260-271DOI: (10.1016/j.jacl.2017.01.002) Copyright © 2017 National Lipid Association Terms and Conditions